QT Imaging Holdings, Inc. announced financial results for the fourth quarter and full year ended December 31, 2025, reporting record revenue of $8.3 million and $18.9 million respectively, exceeding full-year guidance of $18.0 million with 40 scanners shipped. The company affirmed 2026 revenue guidance of approximately $39 million driven by contracted scanner minimum order quantities and initial QTI Cloud Platform revenue.
Key takeaways
2025 revenue of $18.9 million exceeded $18.0 million guidance with record 40 Breast Acoustic CT scanners shipped.
Q4 2025 revenue of $8.3 million from shipment of 17 scanners to U.S. distributor NXC Imaging.
Affirmed 2026 revenue guidance of approximately $39 million from scanner MOQs and QTI Cloud Platform.
AMA approved Category III CPT code X579T for Breast Acoustic CT, effective January 1, 2027.
FDA 510(k) clearance for updated Breast Acoustic CT scanner configuration.
UAE exclusive distribution agreement with Al Naghi Medical Co. for minimum 7 scanners in 2026, 16 in 2027, 20 in 2028 (total 43 scanners, >$24 million revenue).